As part of a multi-year RWE initiative, AMCP Research Institute partnered with IQVIA, payers, pharmaceutical companies, and others to design payer-focused RWE standards that were published in JMCP in September, 2025.
AMCP Letter for the Record to House Energy and Commerce Committee in Support of Opioid Legislation - H.R. 3528, H.R. 4275 and H.R. 4841
The Academy of Managed Care Pharmacy (AMCP) strongly supports the committee’s drive to combat the opioid epidemic. While searching for solutions to a widespread problem which has impacted the lives of many across the nation, there has been a consensus that no “one size fits all” solution exists and therefore AMCP believes that a holistic, comprehensive, and multi-stakeholder approach among health care providers and patients is necessary to truly address the opioid epidemic. This can be seen in the depth and breadth of bills which Energy and Commerce has brought forward for markup.
Related
AMCP’s guidance translates CMS’s expectations for patient centered, evidence informed formulary decisions into practical steps payers can act on today without adding unnecessary burden to P&T workflows.
AMCP launched the metabolic health thought leadership program to empower payers to shift from siloed treatment to holistic, root-cause-focused metabolic health management—redefining roles in benefit design and population outcomes—starting immediately with the new ADA 2026 CGM expansions that are reshaping coverage and access.
Featured News & Resources
See Full CalendarUpcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
